The Capital Markets Panel
Bio-Life-Tech 2004 featured a panel of experts on capital markets, discussing all the maturities of investing for growth companies - from early stage through IPOs.
Panel moderated by:
Steve Hurly, Managing Director, Janney Montgomery Scott
Steve Cohen,Partner, Morgan Lewis
Bruce Poignant, Vice President of Marketing, American Stock Exchange
Brian Rye, Director - Equity Research, Janney Montgomery Scott
Gerald Schaafsma, General Partner, Anthem Capital, L.P.
Doug Swirsky, Principal, Head of Life Sciences, Legg Mason Wood Walker, Inc.
Gerald Schaafsma gave the VC view on early stage investing.
Steve Cohen discussed IPO preparation.
Bruce Poignant talked about listing on an exchange.
Brian Rye spoke about the Biotech IPO market from the buy-side point of view.
Doug Swirsky spoke about the state of the capital markets.
These presentations were followed by a question and answer session with the audience.